Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
 
Sign in
Join now
Published in COVID-19 and
1 other channel

Journal Scan / Research · February 03, 2023

Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19

JAMA: The Journal of the American Medical Association

 

 Save  Recommend
 Share

Additional Info

JAMA: The Journal of the American Medical Association
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial
JAMA 2023 Jan 12;[EPub Ahead of Print], MW McCarthy, S Naggie, DR Boulware, CJ Lindsell, TG Stewart, GM Felker, D Jayaweera, M Sulkowski, N Gentile, C Bramante, U Singh, RJ Dolor, J Ruiz-Unger, S Wilson, A DeLong, A Remaly, R Wilder, S Collins, SE Dunsmore, SJ Adam, F Thicklin, G Hanna, AA Ginde, M Castro, K McTigue, E Shenkman, AF Hernandez

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated